Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Type

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 96.

Ciena Corporation, Hanover, MD, USA 2019. Patterned accumulation mode capacitive phase shifter. US 10, 330, 962 B1. [Patent].
file

Hewlett Packard Enterprise Development LP 2019. Category based execution scheduling. 10310877. [Patent].

Hewlett Packard Enterprise Development LP 2018. Recovery services for computing systems. 20180253362. [Patent].

Hewlett Packard Enterprise Development LP 2018. Model-based computer attack analytics orchestration. 20180004941. [Patent].

University of Manchester 2017. Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors. WO/2017/017469. [Patent].

University of Groningen 2017. Gold(III) compounds as tartrate resistant acid phosphatase inhibitors, and therapeutic uses thereof. WO2017058012 (A1). [Patent].

Re:Viral Ltd 2016. Spiro-indolines for the treatment and prophylaxis of respiratory syncytial virus infection (RSV). WO2016055780A1. [Patent].

Janssen Pharmaceuticals, Inc. 2016. Triazoles as nr2b receptor inhibitors. WO2016025917A1. [Patent].

Janssen Pharmaceuticals, Inc. 2016. Pyrazoles as NMDA NR2B receptor inhibitors and their preparation. WO2016025918A1. [Patent].

University College Cardiff Consultants Ltd. 2016. Surface plasmon four-wave mixing microscopy. US8817261 B2. [Patent].

Marie Davidová 2015. The facade and roofing system that is ventilating in dry conditions and enclosing in humid weather / Fasádní a krytinový systém, větrající za sucha a uzavírající se za vlhkého počasí. 307893. [Patent].
file

MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. 2014. Synthesis of diverse glycosylphosphatidylinositol glycans from toxoplasma gondii and their application as vaccines and diagnostics. WO2014016317 A1. [Patent].

Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. 2014. Synthesis of diverse glycosylphosphatidylinositol glycans and glycolipids from toxoplasma gondii and their application as diagnostic markers and vaccines. EP2690438 A1. [Patent].

Iqbal, Sarwat 2014. Process for producing a fructoside-containing product. WO 2014196861 A1 20141211. [Patent].

Iqbal, Sarwat 2014. Catalyst for selective synthesis of lower hydrocarbons from syngas. WO 2014174374 A2 20141030. [Patent].

University of Sussex 2013. Neurodevelopmental disorders. WO 2013/038200 A2. [Patent].

Hewlett Packard Development Co. 2013. Keyword determination based on a weight of meaningfulness. 8375022. [Patent].

Baker, T., Day, R., Phillips, N., University College Cardiff Consultants Ltd. 2012. Physical Performance Assessment. PCT/GB2012/051148. [Patent].

Saudi Basic Industries Corporation 2012. Carbon supported cobalt and molybdenum catalyst. WO 2012143131 A1. [Patent].

Convergence Pharmaceutical Ltd 2012. Piperazine derivatives as cav2.2 calcium channel blockers. WO2012098400A1. [Patent].

University College Cardiff Consultants Ltd 2012. Methods for the nitration of aromatic compounds. WO2012/049513 A1. [Patent].
file

University College Cardiff Consultants Ltd 2012. Catalyst, method of manufacture and use thereof. Patent WO 2012035737. [Patent].

Convergence Pharmaceuticals Ltd 2012. Tetrazole compounds as calcium channel blockers. WO2012004604A1. [Patent].

Q Chip Limited 2012. Microfluidic device and methods for construction and application. EP1562708B1. [Patent].

Iqbal, Sarwat 2012. Carbon supported cobalt and molybdenum catalyst. WO 2012143131 A1 20121026. [Patent].

Medaphor Limited 2011. Ultrasound simulation training system. WO2011124922A1. [Patent].

United States of America as represented by the Secretary of the Department of Health and Human Services; Centers for Disease Control and Prevention; Creare Inc. 2011. Aerosol delivery systems and methods. Patent US 07954486. [Patent].

Zedira GmbH 2011. Transglutaminase 6 as a diagnostic indicator of autoimmune diseases. EP 1 978 364 B1. [Patent].

Cardiff University 2011. Intelligent Rehabilitation. GB1108577.6. [Patent].

University College Cardiff Consultants Ltd 2011. Hydrocarbon selective oxidation with heterogeneous gold catalysts. Patent WO 2011051642. [Patent].

University College Cardiff Consultants Limited, Katholieke Universiteit Leuven 2011. Anti-viral pyrimidine nucleoside derivatives. EP 2016081 B1. [Patent].

University College Cardiff Consultants Ltd 2011. Organometallic sensor device. Patent GB2458090. [Patent].

Glaxo Group Limited 2010. Compounds which potentiate the ampa receptor and uses thereof in medicine. WO2010066658A1. [Patent].

Glaxo Group Limited 2010. N- inden- 2 -yl- isopropylsulfonamides as ampa receptor potentiators. WO2010057865A1. [Patent].

Glaxo Group Limited 2010. Compounds which potentiate the ampa receptor and uses thereof in medicine. WO2010037760. [Patent].

Glaxo Group Limited 2010. Pyrazolo [1, 5-a] pyrimidine derivatives. WO2010007074A1. [Patent].

Hill's Pet Nutrition, Inc. 2010. Method for decreasing cartilage damage in dogs. US20100261793A1. [Patent].

University of Birmingham 2010. Engineering of Plants to exhibit Self-Incompatibility. WO 2010/061181 I A1. [Patent].

Glaxo Group Limited 2009. Compounds which potentiate the ampa receptor and uses thereof in medicine. WO2009092712A1. [Patent].

Glaxo Group Limited 2009. Compounds which potentiate the ampa receptor and uses thereof in medicine. WO2009092713A1. [Patent].

Glaxo Group Limited 2009. Compounds which potentiate the ampa receptor and uses thereof in medicine. WO2009080637A1. [Patent].

Glaxo Group Limited 2009. Compounds which potentiate ampa receptor and uses thereof in medicine. WO2009053448A1. [Patent].

Glaxo Group Limited 2009. Thiazoles which potentiate ampa receptor and medicinal uses thereof. WO2009053449A1. [Patent].

Signal Conversion Limited 2009. Apparatus and methods for the measurement of non-linear distortion of transducer devices. GB2426404. [Patent].

Biostatus Limited 2009. Anthraquinone and its derivatives. 7605280. [Patent].

University College Cardiff Consultants Ltd 2009. Microtrench and tumour proliferation assay. WO/2009/095666. [Patent].

Glaxo Group Limited 2008. Compounds which potentiate AMPA receptor and uses thereof in medicine. WO2008113795. [Patent].

Glaxo Group Limited 2008. Compounds which potentiate ampa receptor and uses thereof in medicine. WO2008110566A1. [Patent].

Glaxo Group Limited 2008. Compounds which potentiate ampa receptor and uses therof in medicine. WO2008148832A1. [Patent].

Barrow, David Anthony 2008. Microfluidic liquid separation device and methods for construction and application. GB 0816001.2. [Patent].

University of Wales 2008. Screening methods and sequences relating thereto. US7393940B2. [Patent].

Iowa State University Research Foundation, Inc. 2008. A1MgB14 and related icosahedral boride semiconducting materials for neutron sensing applications. US7375343. [Patent].

Glaxo Group Limited 2008. Compounds which potentiate ampa receptor and uses thereof in medicine. WO2008053031A1. [Patent].

Iowa State University Research Foundation, Inc. 2008. Magneto-optic remote sensor for angular rotation, linear displacements, and evaluation of surface deformations. US7365533. [Patent].

Iowa State University Research Foundation, Inc. 2008. Cobalt ferrite based magnetostrictive materials for magnetic stress sensor and actuator applications. US7326360. [Patent].

University College Cardiff Consultants, Ltd. 2008. Method of measuring the affinity of biomolecules. EP1949104A2. [Patent].

Cancer Research Technology LTD 2008. Detecting objects. WO/2008/090330. [Patent].

Biostatus Limited 2008. Gel formulations and uses thereof. 20080182287. [Patent].

Glaxo Group Limited 2007. Compounds which potentiate ampa receptor and uses thereof in medicine. WO2007122241A1. [Patent].

Glaxo Group Limited 2007. Compounds which potentiate ampa receptor and uses thereof in medicine. WO2007107539A1. [Patent].

Glaxo Group Limited 2007. 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia. WO2007090840A1. [Patent].

Glaxo Group Limited 2007. Compounds which potentiate glutamate receptor and uses thereof in medicine. WO2007090841A1. [Patent].

Orthogene LLC 2007. Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same. US patent 7, 196,180. [Patent].

Glaxo Group Limited 2006. Acylated piperidihes as glycine transporter inhibitors. WO2006094842. [Patent].

Glaxo Group Limited 2006. Compounds which potentiate glutamate receptor and uses thereof in medicine. WO2006087169A1. [Patent].

Glaxo Group Limited 2006. Glycine transport inhibitors. WO2006067423A1. [Patent].

Glaxo Group Limited 2006. Glycine transport inhibitors. WO2006067417A1. [Patent].

Glaxo Group Limited 2006. Compounds which potentiate glutamate receptor and uses thereof in medicine. WO 2006015827. [Patent].

Glaxo Group Limited 2006. Compounds which potentiate glutamate receptor and uses thereof in medicine. WO 2006015828. [Patent].

Glaxo Group Limited 2006. Compounds which potentiate glutamate receptor and uses thereof in medicine. WO2006015829. [Patent].

2006. Decorrelation of signals. US Patent Application 20060020428; Worldwide patent application WO/2004/051501. [Patent].

Zedira 2006. Transglutaminase gene products. US patent 7,052,890. [Patent].

Destree Olivier, Fahnert Beatrix, Neubauer Peter, Vainio Seppo, Veijola Johanna 2005. Process for producing active Wnt proteins in prokaryotes. WO2005123765 A1. [Patent].

Glaxo Group Limited 2005. Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors. WO 2005014552. [Patent].

Glaxo Group Limited 2004. Benzoxazinone derivatives having affinity for 5- ht receptors, their preparation and use. WO 2004099198. [Patent].

Glaxo Group Limited 2004. Benzoxazinone derivatives, their preparation and use. WO2004099196A1. [Patent].

2004. Novel microfluidic geometries and processing methodologies enabling the precision formation of micro- and nano- particles. WO2004/043598. [Patent].

David Anthony Barrow, Kostas Bouris, Nicola Harries, Tyrone Gwyn Jones, University College Cardiff Consultants Limited 2004. Method for the bulk machining of fluoropolymer substrates. WO2004044655A1. [Patent].

Immundiagnostik AG 2004. Diagnosis of gluten sensitive enteropathy and other autoimmunopathies. European Patent 1,200,827. [Patent].

Glaxo Group Limited 2003. Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy. WO2003068772A1. [Patent].

Glaxo Group Limited 2003. Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors. WO2003068771A1. [Patent].

Glaxo Group Limited 2003. Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders. WO2003068760A2. [Patent].

Glaxo Group Limited 2003. Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptors. WO2003068236A1. [Patent].

Orthogene LLC 2003. Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same. US patent 6,630,457. [Patent].

Inst Molekulare Biotechnologie 2001. Producing a modified L-form bacterial strain by culturing the strain in complex medium and subjecting it to temperature stress, provides bacteria useful to produce recombinant proteins. DE10011358 A1. [Patent].

Knoell Hans Forschung Ev 2001. Producing active bone morphogenic protein dimers, useful for inducing growth of bone and cartilage comprises expressing soluble fusion protein monomer followed by refolding and dimerization. DE19944626 A1. [Patent].

Vernalis Research Limited 2000. 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission. WO2000044371A1. [Patent].

Vernalis Research Limited 2000. 4-quinolinemethanol derivatives as purine receptor antagonists (i). WO2000013681A2. [Patent].

Wisconsin Alumni Research Foundation 2000. Transglutaminase and gene encoding same. US patent 6,020,178. [Patent].

Wisconsin Alumni Research Foundation 2000. Transglutaminase and gene encoding same. US patent 6,114,119. [Patent].

Cerebrus Pharmaceuticals Limited 1999. 1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission. WO1999031051A1. [Patent].

Gen-Probe Incorporated 1998. Labeled hybridization assay probes useful for the detection and quantification of multiple nucleic acid sequences. US5840873A. [Patent].

Orthogene, Inc 1998. Method of promoting adhesion between tissue surfaces. US patent 5,736,132. [Patent].

Ineos Acrylics UK Ltd. 1998. Process for the preparation of bisphosphines. GB/9805348. [Patent].

Gen-Probe Incorporated 1996. Detecting or quantifying multiple analytes using labelling techniques. EP 0478626 B1. [Patent].

Orthogene, Inc 1996. Biological adhesive composition and method of promoting adhesion between tissue surfaces. US patent 5,549,904. [Patent].

This list was generated on Mon Sep 16 13:26:32 2019 BST.